FindTrial
Sign In

Randomized control trial to know about effectiveness of pneumococcal vaccine in indian older adults

Randomized placebo controlled trial to assess clinical and immunological efficacy of pneumococcal vaccine in indian older adults

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/04/013486
Enrollment
70
Registered
2018-04-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- PT AGE 65 YEARS AND ABOVE

Interventions

Intervention1: pneumococcal vaccine 0.5 ml i.m: half patient will be given 0.5 ml of pneumococcal vaccine,while other half patient will be given 0.5 ml of normal saline

Sponsors

Ministry of Health
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: pt aged 65 years and above,consent to participate

Exclusion criteria

Exclusion criteria: withdrawl of consent, allergic reaction to any component of vaccine, prior pneumococcal vaccine, condition which affect follow up such as severe dementia, severe neurological condition, severe frailty

Design outcomes

Primary

MeasureTime frame
TO assess immunological EFFICACY OF PNEUMOCOCCAL VACCINE in indian older adultsTimepoint: TO assess immunological EFFICACY OF PNEUMOCOCCAL VACCINE IN INDIAN OLDER ADULTS—

Secondary

MeasureTime frame
TO KNOW ABOUT CLINICAL EFFICACY OF PNEUMOCOCCAL VACCINE IN INDIAN OLDER ADULTSTimepoint: 0,1, 6 OR 12 MONTHS—

Countries

India

Contacts

Public ContactDr prashun chattarjee

AIIMS

drprasun.geriatrics@gmail.com9013632920

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026